Metabolic syndrome: pathogenesis, medical care and dental implications |
| |
Authors: | Friedlander Arthur H Weinreb Jane Friedlander Ida Yagiela John A |
| |
Affiliation: | Graduate Medical Education, VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA. arthur.friedlander@med.va.gov |
| |
Abstract: | BACKGROUND: The dental literature contains little information about metabolic syndrome (MetS) and its dental implications. TYPES OF STUDIES REVIEWED: The authors conducted a MEDLINE search for the period 2000 through 2005, using the term "metabolic syndrome" to define its pathophysiology, medical treatment and dental implications. RESULTS: MetS is the co-occurrence of abdominal obesity, hyper-triglyceridemia, reduced high-density lipoprotein cholesterol levels, hypertension and impaired fasting glucose, which results from consumption of a high-calorie diet and decreased levels of physical activity superimposed on the appropriate genetic setting. Components of MetS synergistically promote the development of atherosclerosis, resulting in myocardial infarction and stroke. CLINICAL IMPLICATIONS: Deteriorating oral health status is associated with worsening of the atherogenic profile. Tooth loss often results in chewing difficulties because of inadequate occlusive surfaces and may lead to alterations in food selection and dietary quality. This, in turn, adversely affects body composition and nutritional status, both of which are related to vascular health. Dentists should develop treatment plans that preserve and restore the dentition, thus ensuring maximum masticatory efficiency and affording patients the optimum opportunity to consume food that will not foster atherogenesis. |
| |
Keywords: | Hypertension obesity atherosclerosis metabolic syndrome ACE" },{" #name" :" keyword" ," $" :{" id" :" cekeyw60" }," $$" :[{" #name" :" text" ," _" :" Angiotensin-converting enzyme BMI" },{" #name" :" keyword" ," $" :{" id" :" cekeyw80" }," $$" :[{" #name" :" text" ," _" :" Body mass index CYP3A4" },{" #name" :" keyword" ," $" :{" id" :" cekeyw100" }," $$" :[{" #name" :" text" ," _" :" Cytochrome P450 isoform 3A4 FDA" },{" #name" :" keyword" ," $" :{" id" :" cekeyw120" }," $$" :[{" #name" :" text" ," _" :" Food and Drug Administration FFAs" },{" #name" :" keyword" ," $" :{" id" :" cekeyw140" }," $$" :[{" #name" :" text" ," _" :" Free fatty acids HDL-C" },{" #name" :" keyword" ," $" :{" id" :" cekeyw160" }," $$" :[{" #name" :" text" ," _" :" High-density lipoprotein cholesterol IR" },{" #name" :" keyword" ," $" :{" id" :" cekeyw180" }," $$" :[{" #name" :" text" ," _" :" Insulin resistance LDL" },{" #name" :" keyword" ," $" :{" id" :" cekeyw200" }," $$" :[{" #name" :" text" ," _" :" Low-density lipoprotein LDL-C" },{" #name" :" keyword" ," $" :{" id" :" cekeyw220" }," $$" :[{" #name" :" text" ," _" :" Low-density lipoprotein cholesterol MetS" },{" #name" :" keyword" ," $" :{" id" :" cekeyw240" }," $$" :[{" #name" :" text" ," _" :" Metabolic syndrome NHANES III" },{" #name" :" keyword" ," $" :{" id" :" cekeyw260" }," $$" :[{" #name" :" text" ," _" :" Third National Health and Nutrition Examination Survey PDGF" },{" #name" :" keyword" ," $" :{" id" :" cekeyw280" }," $$" :[{" #name" :" text" ," _" :" Platelet-derived growth factor |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|